• Causes include infiltration by fibrosis (interstitial fibrosis), abnormal cells (lymphangitis carcinomatosa), or fluid (pulmonary oedema) • Smooth interlobular septal thickening: pulmonary oedema or alveolar proteinosis • Irregular interlobular septal thickening: lymphangitic spread of tumour or the nodular septal thickening seen in sarcoidosis • A fine reticular pattern (most commonly seen with idiopathic pulmonary fibrosis) • A coarse reticular pattern: this occurs with severe fibrosis and is characterized by interlacing irregular linear opacities an end-stage fibrotic (honeycomb) lung is characterized by cystic airspaces surrounded by irregular walls Traction bronchiectasis/bronchiolectasis: extensive fibrosis can distort the lung morphology resulting in irregular segmental or subsegmental airway dilatation • Ground-glass opacification (if the septal thickening is very fine) • Progressive fibrosis and end-stage lung destruction of unknown cause • It is also known as cryptogenic fibrosing alveolitis (CFA) or usual interstitial pneumonia (UIP) UIP specifically refers to the histopathological pattern seen in patients with the clinical presentation of CFA or IPF • A clinicopathological entity of an isolated organizing pneumonia seen in patients without an identifiable associated disease (e.g. infection, malignancy or connective tissue disease) • COP was previously known as bronchiolitis obliterans organizing pneumonia (BOOP) • This is characterized by alveolar space filling with macrophages and a strong association with cigarette smoking • RB–ILD and DIP are part of the same disease spectrum, with DIP the more severe form • RB–ILD: areas of patchy ground-glass opacification (due to macrophage accumulation within the alveolar spaces and ducts) poorly defined low attenuation centrilobular nodules upper lobe centrilobular emphysema and areas of air trapping (usually to a limited extent and reflecting the bronchiolitic element) • DIP: ground-glass opacification is also the dominant feature this typically affects the peripheral lower zones and may be patchy occasionally there are features of established fibrosis (which is usually to a limited extent) • A multisystem non-caseating granulomatous disorder of unknown aetiology • The lungs, hilar and mediastinal nodes are the most commonly affected organ system • Lung granulomas have a characteristic distribution along the lymphatics within the bronchovascular sheath, interlobular septa and subpleural regions • Lymph nodes appear lobulated with a well-demarcated outline (they can be massive) they can calcify in a characteristic ‘eggshell’ fashion airway or vascular compression is unusual • Garland’s triad: bilateral symmetrical hilar and paratracheal lymphadenopathy The lymphadenopathy can occasionally (1–5%) be asymmetrical or unilateral – marked asymmetry should bring the diagnosis into question unilateral paratracheal lymphadenopathy is usually right-sided (left-sided lymphadenopathy causes enlargement of the aortopulmonary window nodes) • 40% of patients with nodal enlargement will develop parenchymal opacities within 1 year – of these ⅓ will develop persistent fibrotic shadowing (± traction bronchiectasis) • Parenchymal changes appear as any nodal enlargement subsides (these tend to progress in unison in lymphoma) Causes of eggshell nodal calcification* Sarcoidosis • The most common pattern: rounded or irregular moderately well-defined nodules (2–4mm) very small aggregated opacities can give a ground-glass appearance • The second most common pattern: peribronchovascular patchy airspace consolidation this usually demonstrates a nodular pattern but can also contain air bronchograms and have ill-defined margins a conglomerate opacity resembling progressive massive fibrosis can develop • Complications: cor pulmonale bullous disease (± mycetoma formation) pneumothorax • Perilymphatic nodular opacities (1–5mm) within the subpleural regions and along the bronchovascular bundles and interlobular septae (generating irregular and beaded interfaces) larger ill-defined nodules can develop – these rarely cavitate but can demonstrate air bronchograms patchy ground-glass opacification air trapping is commonly seen • Pleural thickening and effusions are unusual (any effusion seen is usually unilateral and small) • Intrinsic mural sarcoidosis can rarely cause airway narrowing (with single or multiple lesions seen down to a segmental level) there is a potential for significant airflow obstruction or atelectasis (particularly involving the middle lobe) • Sarcoidosis is the most common cause of intrathoracic lymph node enlargement symmetry is the important diagnostic feature The anterior mediastinal nodes are occasionally enlarged – posterior mediastinal nodal enlargement is unusual • 67Gallium accumulation is a sensitive but non-specific indicator of active inflammation in sarcoidosis • Diagnosis: transbronchial biopsy
High-resolution computed tomography (HRCT)
HRCT PATTERNS OF DIFFUSE LUNG DISEASE
RETICULAR PATTERN
Definition
HRCT
IDIOPATHIC INTERSTITIAL PNEUMONIAS
IDIOPATHIC PULMONARY FIBROSIS (IPF)
DEFINITION
CRYPTOGENIC ORGANIZING PNEUMONIA (COP)
DEFINITION
IDIOPATHIC INTERSTITIAL PNEUMONIAS
RESPIRATORY BRONCHIOLITIS–INTERSTITIAL LUNG DISEASE (RB–ILD) AND DESQUAMATIVE INTERSTITIAL PNEUMONIA (DIP)
DEFINITION
RADIOLOGICAL FEATURES
HRCT
Clinico–radiological–pathological criteria
Histological pattern
HRCT features*
Idiopathic pulmonary fibrosis
Usual interstitial pneumonia
Peripheral (subpleural) and basal reticular opacities honeycombing areas of ground-glass opacity (associated with traction bronchiectasis)
Non-specific interstitial pneumonia
Non-specific interstitial pneumonia
Areas of ground-glass opacity ± traction bronchiectasis minimal honeycombing
Cryptogenic organizing pneumonia
Organizing pneumonia
Peripheral or peribronchial consolidation areas of ground-glass opacity a perilobular pattern is increasingly recognized
Acute interstitial pneumonia
Diffuse alveolar damage
Consolidation (within the dependent lung) areas of ground-glass opacity traction bronchiectasis (organizing phase)
Respiratory bronchiolitis–interstitial lung (RB–ILD)
RB–ILD
Poorly defined centrilobular nodules areas of ground-glass opacity bronchial wall thickening limited emphysema
Desquamative interstitial pneumonia (DIP)
DIP
Areas of ground-glass opacity features of interstitial fibrosis
Lymphoid interstitial pneumonia (LIP)
LIP
Areas of ground-glass opacity poorly defined centrilobular nodules thickened interlobular septa thin-walled discrete cysts air trapping
SARCOIDOSIS
SARCOIDOSIS
DEFINITION
RADIOLOGICAL FEATURES
CXR (lymphadenopathy)
CXR (parenchymal changes)
Silicosis
Histoplasmosis
Lymphoma (post-irradiation)
Blastomycosis
Amyloidosis
HRCT
Other thoracic findings
PEARLS